0001676047 false 0001676047 2023-03-19 2023-03-19 0001676047 us-gaap:CommonStockMember 2023-03-19 2023-03-19 0001676047 NTRB:WarrantsMember 2023-03-19 2023-03-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 19, 2023

 

Nutriband Inc.

 

Nevada   000-55654   81-1118176

(State or Other Jurisdiction

 of Incorporation)

   (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

121 S. Orange Ave. Suite 1500

Orlando, Florida

   32801
(Address of Principal Executive Offices)   (Zip Code)

 

(407) 377-6695

Registrant’s Telephone Number, Including Area Code

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☒

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common Stock    NTRB    The Nasdaq Stock Market LLC 
Warrants   NTRBW   The Nasdaq Stock Market LLC

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

The Company on March 19, 2023 entered into a three-year $2,000,000 credit line facility, drawdowns under which bear interest at the rate of 7% per annum. The credit line does not permit conversion by the lender of amounts outstanding under the line into common stock. The credit line provides the Company with financing, through the FDA approval process and into commercial scale manufacturing, for the Company’s patented lead product, AVERSA™ Fentanyl, an abuse-deterrent fentanyl transdermal system.

 

See Press Release attached as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

The following exhibits are being filed with this Current Report on Form 8-K:

 

99.1   Nutriband Press Release dated March 28, 2023
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

SIGNATURES

 

PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

 

  NUTRIBAND INC.
     
Date: March 29, 2023 By:  /s/ Gareth Sheridan
  R: Gareth Sheridan
  Chief Executive Officer

 

 

 

 

 

 

 

Nutriband (NASDAQ:NTRB)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Nutriband Charts.
Nutriband (NASDAQ:NTRB)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Nutriband Charts.